Literature DB >> 34058063

Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney.

Claire E Sexton1, Kaarin J Anstey2, Filippo Baldacci3,4, C J Barnum5, Anna M Barron6, Kaj Blennow7,8, Henry Brodaty9, Samantha Burnham10, Fanny M Elahi11, Jürgen Götz12, Yun-Hee Jeon13, Maya Koronyo-Hamaoui14, Susan M Landau15, Nicola T Lautenschlager16,17, Simon M Laws18, Darren M Lipnicki9, Hanzhang Lu19, Colin L Masters20, Wendy Moyle21, Akinori Nakamura22, Giulio Maria Pasinetti23, Naren Rao24, Christopher Rowe20,25, Perminder S Sachdev9,26, Peter R Schofield27, Einar M Sigurdsson28, Kate Smith29, Velandai Srikanth30, Cassandra Szoeke31, Malú G Tansey32, Rachel Whitmer33, Donna Wilcock34, Tien Y Wong35, Lisa J Bain36, Maria C Carrillo1.   

Abstract

The Alzheimer's Association International Conference held its sixth Satellite Symposium in Sydney, Australia in 2019, highlighting the leadership of Australian researchers in advancing the understanding of and treatment developments for Alzheimer's disease (AD) and other dementias. This leadership includes the Australian Imaging, Biomarker, and Lifestyle Flagship Study of Ageing (AIBL), which has fueled the identification and development of many biomarkers and novel therapeutics. Two multimodal lifestyle intervention studies have been launched in Australia; and Australian researchers have played leadership roles in other global studies in diverse populations. Australian researchers have also played an instrumental role in efforts to understand mechanisms underlying vascular contributions to cognitive impairment and dementia; and through the Women's Healthy Aging Project have elucidated hormonal and other factors that contribute to the increased risk of AD in women. Alleviating the behavioral and psychological symptoms of dementia has also been a strong research and clinical focus in Australia.
© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's; behavioral symptoms; biomarkers; dementia; prevention

Mesh:

Substances:

Year:  2021        PMID: 34058063      PMCID: PMC9396711          DOI: 10.1002/alz.12380

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  124 in total

Review 1.  Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models.

Authors:  Senthilkumar Krishnaswamy; Huai-Wei Huang; Isabella S Marchal; Hyung Don Ryoo; Einar M Sigurdsson
Journal:  Neurobiol Dis       Date:  2020-01-23       Impact factor: 5.996

2.  Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center.

Authors:  Teresa Jenica Filshtein; Brittany N Dugger; Lee-Way Jin; John M Olichney; Sarah T Farias; Luis Carvajal-Carmona; Paul Lott; Dan Mungas; Bruce Reed; Laurel A Beckett; Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  The Effectiveness of Social Robots for Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.

Authors:  Lihui Pu; Wendy Moyle; Cindy Jones; Michael Todorovic
Journal:  Gerontologist       Date:  2019-01-09

4.  Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain.

Authors:  Allal Boutajangout; Johanna Ingadottir; Peter Davies; Einar M Sigurdsson
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

5.  The Relationship between Sleep Quality and Brain Amyloid Burden.

Authors:  Belinda M Brown; Stephanie R Rainey-Smith; Victor L Villemagne; Michael Weinborn; Romola S Bucks; Hamid R Sohrabi; Simon M Laws; Kevin Taddei; S Lance Macaulay; David Ames; Christopher Fowler; Paul Maruff; Colin L Masters; Christopher C Rowe; Ralph N Martins
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

6.  The promise of technology in the future of dementia care.

Authors:  Wendy Moyle
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

7.  STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.

Authors:  Perminder S Sachdev; Jessica W Lo; John D Crawford; Lisa Mellon; Anne Hickey; David Williams; Régis Bordet; Anne-Marie Mendyk; Patrick Gelé; Dominique Deplanque; Hee-Joon Bae; Jae-Sung Lim; Amy Brodtmann; Emilio Werden; Toby Cumming; Sebastian Köhler; Frans R J Verhey; Yan-Hong Dong; Hui Hui Tan; Christopher Chen; Xu Xin; Raj N Kalaria; Louise M Allan; Rufus O Akinyemi; Adesola Ogunniyi; Aleksandra Klimkowicz-Mrowiec; Martin Dichgans; Frank A Wollenweber; Vera Zietemann; Michael Hoffmann; David W Desmond; Thomas Linden; Christian Blomstrand; Björn Fagerberg; Ingmar Skoog; Olivier Godefroy; Mélanie Barbay; Martine Roussel; Byung-Chul Lee; Kyung-Ho Yu; Joanna Wardlaw; Stephen J Makin; Fergus N Doubal; Francesca M Chappell; Velandai K Srikanth; Amanda G Thrift; Geoffrey A Donnan; Nagaendran Kandiah; Russell J Chander; Xuling Lin; Charlotte Cordonnier; Solene Moulin; Costanza Rossi; Behnam Sabayan; David J Stott; J Wouter Jukema; Susanna Melkas; Hanna Jokinen; Timo Erkinjuntti; Vincent C T Mok; Adrian Wong; Bonnie Y K Lam; Didier Leys; Hilde Hénon; Stéphanie Bombois; Darren M Lipnicki; Nicole A Kochan
Journal:  Alzheimers Dement (Amst)       Date:  2016-11-18

Review 8.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

9.  High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.

Authors:  Suzanne E Schindler; James G Bollinger; Vitaliy Ovod; Kwasi G Mawuenyega; Yan Li; Brian A Gordon; David M Holtzman; John C Morris; Tammie L S Benzinger; Chengjie Xiong; Anne M Fagan; Randall J Bateman
Journal:  Neurology       Date:  2019-08-01       Impact factor: 11.800

10.  Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.

Authors:  Haoshen Shi; Yosef Koronyo; Altan Rentsendorj; Giovanna C Regis; Julia Sheyn; Dieu-Trang Fuchs; Andrei A Kramerov; Alexander V Ljubimov; Oana M Dumitrascu; Anthony R Rodriguez; Ernesto Barron; David R Hinton; Keith L Black; Carol A Miller; Nazanin Mirzaei; Maya Koronyo-Hamaoui
Journal:  Acta Neuropathol       Date:  2020-02-10       Impact factor: 17.088

View more
  1 in total

1.  Sleep duration, genetic susceptibility, and Alzheimer's disease: a longitudinal UK Biobank-based study.

Authors:  Shiqi Yuan; Wen Ma; Rui Yang; Fengshuo Xu; Didi Han; Tao Huang; MIn Peng; Anding Xu; Jun Lyu
Journal:  BMC Geriatr       Date:  2022-08-02       Impact factor: 4.070

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.